Antibiotic Funding Accelerates

The headline becomes a policy catalyst for antimicrobial-resistance funding rather than a broad market shock. Governments prioritize rapid diagnostics, susceptibility testing, and incentives for antibiotics active against multidrug-resistant Gram-negative pathogens.

Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.